Analysts expect over 2018 rising revenue Carl Zeiss Meditec

Next Monday the German company Carl Zeiss Meditec will publish its past quarter's results. Over the current book year the total revenue will be 1,27 billion euros (consensus estimates). This is slightly more than 2016's revenue of 1,19 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2018

stock

The analysts expect for 2018 a net profit of 135 million euros. The majority of the analysts expects for this year a profit per share of 1,52 euros. The price-earnings-ratio equals 32,28.

Per share the analysts are expecting a dividend of 0,54 cents per share. The dividend yield is then 1,1 percent. The average dividend yield of the pharmaceutical companies is a limited 1 percent.

Latest estimates around 49 euros

The latest 3 recommendations for the pharmaceutical company were provided by Berenberg, Deutsche Bank and Nord Landesbank.

Based on the current number of shares Carl Zeiss Meditec 's market capitalization equals 3,99 billion euros.

At 10.55 the stock trades 0,82 percent higher at 49,06 euros.

Historical stock prices Carl Zeiss Meditec

stock carlzeissmeditec

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.